A Phase 1 Clinical Trial to Evaluate Pharmacokinetics (PK), Pharmacodynamics (PD), and Safety in Healthy Chinese Adults After Multiple Intravenous Administration of Dexlansoprazole
Latest Information Update: 29 Jul 2019
At a glance
- Drugs Dexlansoprazole (Primary) ; Lansoprazole
- Indications Erosive oesophagitis; Gastro-oesophageal reflux
- Focus Pharmacodynamics
- 23 Jul 2019 Status changed from recruiting to completed, according to the results published in the Clinical Drug Investigation
- 23 Jul 2019 Results published in the Clinical Drug Investigation
- 20 Apr 2017 New trial record